South Korea Oligonucleotide Synthesis Market

South Korea Oligonucleotide Synthesis Market Size & Forecast:

• South Korea Oligonucleotide Synthesis Market Size 2025: USD 87.9 Million
• South Korea Oligonucleotide Synthesis Market Size 2033: USD 250.79 Million 
• South Korea Oligonucleotide Synthesis Market CAGR: 14.02%
• South Korea Oligonucleotide Synthesis Market Segments: By Type (DNA, RNA, Modified Oligos, Custom Oligos), By Application (Research, Diagnostics, Therapeutics, PCR), By End-User (Biotech Firms, Pharma Companies, Research Institutes, Labs)

To learn more about this report,  Download Free Sample Report

South Korea Oligonucleotide Synthesis Market Summary:

South Korea Oligonucleotide Synthesis Market size was estimated at USD 87.9 Millionin 2025 and is anticipated to reach USD 250.79 Million by 2033, growing at a CAGR of 14.02% from 2026 to 2033. 

The South Korea oligonucleotide synthesis market will operate as a dedicated segment which creates short DNA and RNA sequences for research purposes, diagnostic testing and developing medical treatments. The laboratory and biotech industry will need precise medical solutions which require their laboratory facilities to produce results faster and create pure materials and develop customized solutions in small quantities. The entire country of scientific research institutions and medical research organizations will continue to demand synthesis services which support their work on gene studies and personalized medicine development.

The market will experience changes because of two main factors which include the rapid development of automated synthesis systems and the better purification techniques and the digital ordering platforms that make complicated sequence creation easier to handle. The genetic research and therapeutic application regulations will establish production requirements which create standards for product quality and testing processes. The requirements of end users include three main objectives which are to have flexible options and to manage expenses and to connect with downstream processes which include sequencing and molecular diagnostics so service providers must develop both their operational methods and their technical capacities.

Key Market Trends & Insights:

• The Oligonucleotide Synthesis Market in South Korea experiences continuous growth because of the increasing application of oligonucleotides in both targeted therapies and molecular diagnostics. The demand for synthesized sequences will remain stable because hospitals and research centers will increasingly adopt precision medicine and genetic testing.
• South Korean Oligonucleotide Synthesis Market expansion results from increased funding that biotechnology and pharmaceutical companies allocate to their research and development activities. Custom oligonucleotides serve as essential tools for research institutions and drug developers who use them in drug discovery and validation processes which results in a stable demand pattern that receives backing from both public and private sectors.
• The Oligonucleotide Synthesis Market in South Korea shows improvements in accuracy and speed and production capacity. The implementation of advanced automation and purification methods enables manufacturers to produce complex sequences while maintaining operational efficiency and reducing production delays. The ongoing research developments will improve operational effectiveness and create new uses for technology.
• The Oligonucleotide Synthesis Market in South Korea experiences growth because more people use genomic testing and personalized treatment methods. The market has gained value for clinical and academic environments because the demand for reliable oligonucleotide supplies has grown due to increased sequencing activities and biomarker identification activities.
• Government policies which support life sciences research and innovation drive growth in the South Korean Oligonucleotide Synthesis Market. Domestic manufacturers gain production opportunities through government-sponsored programs and infrastructure development initiatives which enable them to build partnerships for skill development and international market expansion.

South Korea Oligonucleotide Synthesis Market Segmentation

By Type :

• DNA: The South Korean market for oligonucleotide synthesis maintains constant demand for DNA oligonucleotides because researchers use these products in sequencing, gene analysis and cloning applications. Laboratory procedures will depend on DNA synthesis, enabling scientists to achieve higher precision and faster results. The demand for testing services will increase because academic institutions and commercial companies expand their genomics research operations.
• RNA: RNA oligonucleotide research has become essential because scientists now investigate gene expression and develop RNA-based therapies. The South Korean Oligonucleotide Synthesis Market shows increasing demand for RNA products which scientists use in vaccine research and gene silencing investigations. The increasing demand for mRNA technology and RNA interference will lead to steady growth in this particular market segment.
• Modified Oligos: Research scientists increasingly use modified oligonucleotides because these products offer greater stability and better results in experiments with complicated conditions. The South Korean market for oligonucleotide synthesis shows increasing demand for chemically modified sequences which scientists use in drug research and advanced diagnostic procedures. The modifications will improve binding capacity and resistance against degradation which makes the products ideal for medical applications and research purposes.
• Custom Oligos: Researchers use custom oligonucleotides to create flexible solutions which match their specific experimental requirements. The South Korean Oligonucleotide Synthesis Market expands because researchers increasingly require customized sequences to support their particular research projects. Custom solutions will support innovation by allowing exact sequence creation, helping researchers meet unique project requirements without relying on standard templates.

By Application :

• Research: The South Korean Oligonucleotide Synthesis Market depends on research because universities and institutes require synthesized sequences for their genetic research. The ongoing research in molecular biology and gene editing and sequencing will maintain continuous market demand. The increasing number of funded research projects and partnerships will lead to greater use of oligonucleotide synthesis methods in research settings.
• Diagnostics: The field of diagnostics expands through advanced methods which enable precise testing and early disease detection. South Korea Oligonucleotide Synthesis Market shows strong adoption in diagnostic kits and assays. Oligonucleotides will serve as essential tools for detecting genetic markers and infectious diseases which will enhance diagnostic accuracy and speed across healthcare systems.
• Therapeutics: The therapeutics sector experiences growth because more patients need nucleic acid treatments that treat their genetic diseases. South Korean Oligonucleotide Synthesis Market shows increased funding for drug development which uses antisense and RNA-based therapies. The methods will create specific treatment solutions which will enhance patient results while they drive medical progress.
• PCR: Laboratories depend on PCR applications to perform both amplification and detection tasks. The South Korea Oligonucleotide Synthesis Market benefits from the ongoing use of primers which scientists use in their PCR procedures. The demand for PCR testing will remain strong because this method offers accurate and fast genetic testing solutions which support clinical testing and research activities.

To learn more about this report,  Download Free Sample Report

By End-User :

• Biotech Firms: Biotech firms act as key contributors by using oligonucleotides in product development and innovation. The South Korean Oligonucleotide Synthesis Market experiences strong demand from this group because genetic engineering work continues and molecular tools development proceeds. The biotechnology industry will experience growth through continuous funding which will drive research into advanced synthesis technologies.
• Pharma Companies: Pharmaceutical companies depend on oligonucleotides during the entire drug discovery process which includes drug development. The South Korean Oligonucleotide Synthesis Market experiences benefits from the growing interest in targeted therapies and personalized medicine. The application of synthesized sequences will enhance drug design abilities while enabling the creation of innovative treatment methods for intricate medical conditions.
• Research Institutes: Research institutes require ongoing access to resources because they participate in both academic research and scientific investigations. The South Korean Oligonucleotide Synthesis Market receives support from government funding together with financial backing from institutional research efforts. Research institutes will maintain their need for high-quality oligonucleotides because these materials constitute essential components of their scientific work leading to continuous market expansion.
• Labs: The basic operational structure of laboratories supports their work in testing and experimental procedures. The South Korean Oligonucleotide Synthesis Market demonstrates the ongoing requirement for synthesized sequences that laboratories need to perform their daily operations. Laboratories at both small and large facilities will maintain their need for dependable supplies which will create ongoing demand throughout both types of environments.

Country Insights

• The South Korea Oligonucleotide Synthesis Market keeps growing because the country shows its strength in biotechnology and pharmaceutical manufacturing. The academic institutions and industrial organizations have gained access to oligonucleotide research resources through the combination of advanced research facilities and ongoing life sciences funding. The availability of qualified experts together with rising interest in genetic studies will create increased demand for medical and research purposes.
• The South Korea Oligonucleotide Synthesis Market developed through government backing according to its current state. Investment in synthesis technologies received support from policies that targeted precision medicine genomics and drug development. The establishment of public and private partnerships has enhanced laboratory infrastructure which enables companies and research institutions to implement modern synthesis techniques while maintaining efficient production processes.
• The South Korean Oligonucleotide Synthesis Market expands because of growing healthcare requirements and improving public understanding of personalized medicine solutions. The rising prevalence of chronic illnesses together with the demand for precise medical treatments has led to increased dependence on oligonucleotide-based therapeutic options. Local companies will expand their technical capabilities through partnerships with international organizations to enhance their ability to deliver superior synthesis solutions.

Recent Development News

Government creates $34 billion strategic tech fund (biopharma included)

March 2025, The South Korean government established a $34 billion policy fund to support essential industries which include semiconductor and biopharmaceutical sectors. This funding development led to increased investment in oligonucleotide synthesis facilities and cutting-edge therapeutic research.

Roche invests $481 million in South Korean biotech ecosystem

In March 2026, Roche announced a $481 million investment in South Korea's biotech sector which strengthened the country's status as a center for advanced drug development that includes nucleic acid therapies and oligonucleotide manufacturing.

Key South Korea Oligonucleotide Synthesis Company Insights

• South Korea Oligonucleotide Synthesis market experiences constant growth because of strong biotechnology research activities and pharmaceutical manufacturing operations. Companies that lead the industry work to develop better synthesis methods while they expand their production capabilities. The industry widely uses advanced technologies which include automated synthesizers and purification systems to achieve uniform product quality in their high-volume oligonucleotide production processes.
• The South Korea Oligonucleotide Synthesis market experiences competitive activity because research facility investments and academic partnerships have increased. Companies provide custom synthesis services because diagnostic and therapeutic development needs are increasing. The government supports innovation through funding programs which help domestic capabilities while making the country more competitive in the global market for oligonucleotide production. 

South Korea Oligonucleotide Synthesis Market Companies:

• Thermo Fisher
• Agilent
• Eurofins
• Merck KGaA
• Danaher
• Twist Bioscience
• GenScript
• IDT
• LGC Biosearch
• Bioneer
• Macrogen
• Takara Bio
• Bio-Synthesis
• TriLink
• Kaneka

South Korea Oligonucleotide Synthesis Market Segmentation

By Type

• DNA
• RNA
• Modified Oligos
• Custom Oligos

By Application

• Research
• Diagnostics
• Therapeutics
• PCR

By End-User

• Biotech Firms
• Pharma Companies
• Research Institutes
• Labs